510(k) K122793
K122793 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON TESTOSTERONE; LIAISON TESTOSTERONE CONTROL SET". The FDA issued a decision of Substantially Equivalent on January 25, 2013. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 25, 2013
- Date Received
- September 12, 2012
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Testosterones And Dihydrotestosterone
- Device Class
- Class I
- Regulation Number
- 862.1680
- Review Panel
- CH
- Submission Type